Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-08

Clinical Trial Update: Single-dose Intravenous Iron Therapy for Anemia After Orthopaedic Trauma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating a single-dose intravenous iron therapy to treat anemia after orthopedic trauma and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intravenous iron therapy (iron (intravenous))

Snippet

Sponsor: Oregon Health and Science University | Conditions: Acute Blood Loss Anemia, Fracture | Phase 4 | Status: RECRUITING